Intellia Therapeutics
NTLA
NTLA
275 hedge funds and large institutions have $934M invested in Intellia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 109 increasing their positions, 87 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
-16
Holders Change %
-5.5%
% of All Funds
3.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
109
Reduced
87
Closed
52
Calls
$18.2M
Puts
$11.2M
Net Calls
+$7M
Net Calls Change
+$6.39M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$19.1M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$11.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$7.43M |
| 4 |
Renaissance Technologies
New York
|
+$6.35M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$4.9M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$26.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.2M |
| 3 |
CC
Casdin Capital
New York
|
-$14.2M |
| 4 |
BlackRock
New York
|
-$4.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.84M |
